Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
about
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerSDF-1/CXCL12: A Chemokine in the Life Cycle of HIVA single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.Effects of CCR5 59029G/A polymorphism on the risk to diabetic nephropathy.
P2860
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
@ast
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
@en
type
label
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
@ast
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
@en
prefLabel
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
@ast
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
@en
P2093
P2860
P50
P356
P1476
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry
@en
P2093
Anne Brelot
Arzu Demir
Cécile Ferret
Fernando Arenzana-Seisdedos
Isabelle Staropoli
Nathalie Sauvonnet
Oliver Hartley
Sophie Rogée
P2860
P304
19042-19052
P356
10.1074/JBC.M114.559831
P407
P50
P577
2014-05-22T00:00:00Z